Antimitotic drugs.
Chabner
B A
BA
Division of Cancer Treatment, National Cancer Institute, Bethesda, MD.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D004351:Drug Resistance / Q000502:physiology; D006801:Humans; D017239:Paclitaxel / Q000494:pharmacology; D011485:Protein Binding; D014404:Tubulin / Q000378:metabolism; D014748:Vinca Alkaloids / Q000494:pharmacology
D000970:Antineoplastic Agents; D014404:Tubulin; D014748:Vinca Alkaloids; D017239:Paclitaxel